Agmatine ameliorates diabetes type 2-induced nephropathy in rats
Objective: To assess the nephroprotective potential of agmatine in a rat model of streptozotocin-induced diabetic nephropathy. Methods: A single dose of streptozotocin (40 mg/kg) coupled with a fructose diet induced diabetes in Wistar rats. Agmatine (40 and 80 mg/kg) was administered to rats for 12...
Main Authors: | , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2024-01-01
|
Series: | Asian Pacific Journal of Tropical Biomedicine |
Subjects: | |
Online Access: | http://www.apjtb.org/article.asp?issn=2221-1691;year=2024;volume=14;issue=1;spage=8;epage=16;aulast=Kamel |
_version_ | 1797246472828223488 |
---|---|
author | Fatemah O Kamel Ohoud Shagroud Mai A.Alim A.Sattar Ahmad Gamal S Abd El-Aziz Abdulhadi S Burzangi Duaa Bakhshwin Maha Jamal Shahid Karim |
author_facet | Fatemah O Kamel Ohoud Shagroud Mai A.Alim A.Sattar Ahmad Gamal S Abd El-Aziz Abdulhadi S Burzangi Duaa Bakhshwin Maha Jamal Shahid Karim |
author_sort | Fatemah O Kamel |
collection | DOAJ |
description | Objective: To assess the nephroprotective potential of agmatine in a rat model of streptozotocin-induced diabetic nephropathy.
Methods: A single dose of streptozotocin (40 mg/kg) coupled with a fructose diet induced diabetes in Wistar rats. Agmatine (40 and 80 mg/kg) was administered to rats for 12 weeks. The body weight and fasting blood glucose were measured weekly. Insulin level, urine output, total protein, albumin, blood urea nitrogen, creatinine, and cystatin-C were also determined at the end of the experiment. Furthermore, superoxide dismutase, glutathione, interleukin-1β, interleukin-6, and tumor necrosis factor-alpha were evaluated in kidney tissue. Histopathological study was also performed using hematoxylin and eosin staining.
Results: Agmatine at both doses significantly increased final body weight, and lowered fasting blood glucose, urine output, insulin, total protein, albumin, blood urea nitrogen, creatinine, and cystatin-C levels compared with the diabetic group (P < 0.05). Inflammatory markers and antioxidant effect were significantly improved in agmatine-treated rats. Moreover, the histopathological changes in renal structure were ameliorated by agmatine treatment.
Conclusions: Agmatine alleviates diabetic nephropathy by improving renal functions and reducing inflammation and oxidative stress. The molecular mechanisms of its nephroprotective actions need to be investigated in future study. |
first_indexed | 2024-04-24T19:43:21Z |
format | Article |
id | doaj.art-b83d1f9b0f7e42dfb2db41f787a82185 |
institution | Directory Open Access Journal |
issn | 2221-1691 2588-9222 |
language | English |
last_indexed | 2024-04-24T19:43:21Z |
publishDate | 2024-01-01 |
publisher | Wolters Kluwer Medknow Publications |
record_format | Article |
series | Asian Pacific Journal of Tropical Biomedicine |
spelling | doaj.art-b83d1f9b0f7e42dfb2db41f787a821852024-03-25T10:07:16ZengWolters Kluwer Medknow PublicationsAsian Pacific Journal of Tropical Biomedicine2221-16912588-92222024-01-0114181610.4103/2221-1691.393580Agmatine ameliorates diabetes type 2-induced nephropathy in ratsFatemah O KamelOhoud ShagroudMai A.Alim A.Sattar AhmadGamal S Abd El-AzizAbdulhadi S BurzangiDuaa BakhshwinMaha JamalShahid KarimObjective: To assess the nephroprotective potential of agmatine in a rat model of streptozotocin-induced diabetic nephropathy. Methods: A single dose of streptozotocin (40 mg/kg) coupled with a fructose diet induced diabetes in Wistar rats. Agmatine (40 and 80 mg/kg) was administered to rats for 12 weeks. The body weight and fasting blood glucose were measured weekly. Insulin level, urine output, total protein, albumin, blood urea nitrogen, creatinine, and cystatin-C were also determined at the end of the experiment. Furthermore, superoxide dismutase, glutathione, interleukin-1β, interleukin-6, and tumor necrosis factor-alpha were evaluated in kidney tissue. Histopathological study was also performed using hematoxylin and eosin staining. Results: Agmatine at both doses significantly increased final body weight, and lowered fasting blood glucose, urine output, insulin, total protein, albumin, blood urea nitrogen, creatinine, and cystatin-C levels compared with the diabetic group (P < 0.05). Inflammatory markers and antioxidant effect were significantly improved in agmatine-treated rats. Moreover, the histopathological changes in renal structure were ameliorated by agmatine treatment. Conclusions: Agmatine alleviates diabetic nephropathy by improving renal functions and reducing inflammation and oxidative stress. The molecular mechanisms of its nephroprotective actions need to be investigated in future study.http://www.apjtb.org/article.asp?issn=2221-1691;year=2024;volume=14;issue=1;spage=8;epage=16;aulast=Kamelagmatine; type 2 diabetes; nephropathy; oxidative stress; nephroprotection |
spellingShingle | Fatemah O Kamel Ohoud Shagroud Mai A.Alim A.Sattar Ahmad Gamal S Abd El-Aziz Abdulhadi S Burzangi Duaa Bakhshwin Maha Jamal Shahid Karim Agmatine ameliorates diabetes type 2-induced nephropathy in rats Asian Pacific Journal of Tropical Biomedicine agmatine; type 2 diabetes; nephropathy; oxidative stress; nephroprotection |
title | Agmatine ameliorates diabetes type 2-induced nephropathy in rats |
title_full | Agmatine ameliorates diabetes type 2-induced nephropathy in rats |
title_fullStr | Agmatine ameliorates diabetes type 2-induced nephropathy in rats |
title_full_unstemmed | Agmatine ameliorates diabetes type 2-induced nephropathy in rats |
title_short | Agmatine ameliorates diabetes type 2-induced nephropathy in rats |
title_sort | agmatine ameliorates diabetes type 2 induced nephropathy in rats |
topic | agmatine; type 2 diabetes; nephropathy; oxidative stress; nephroprotection |
url | http://www.apjtb.org/article.asp?issn=2221-1691;year=2024;volume=14;issue=1;spage=8;epage=16;aulast=Kamel |
work_keys_str_mv | AT fatemahokamel agmatineamelioratesdiabetestype2inducednephropathyinrats AT ohoudshagroud agmatineamelioratesdiabetestype2inducednephropathyinrats AT maiaalimasattarahmad agmatineamelioratesdiabetestype2inducednephropathyinrats AT gamalsabdelaziz agmatineamelioratesdiabetestype2inducednephropathyinrats AT abdulhadisburzangi agmatineamelioratesdiabetestype2inducednephropathyinrats AT duaabakhshwin agmatineamelioratesdiabetestype2inducednephropathyinrats AT mahajamal agmatineamelioratesdiabetestype2inducednephropathyinrats AT shahidkarim agmatineamelioratesdiabetestype2inducednephropathyinrats |